K P Bhatia Selected Research

K P Bhatia Research Topics

Disease

12	Dystonia (Limb Dystonia) 04/2016 - 06/2004
8	Torticollis (Wryneck) 01/2011 - 09/2000
6	Parkinsonian Disorders (Parkinsonism) 02/2024 - 04/2006
4	Movement Disorders (Movement Disorder) 08/2016 - 06/2004
4	Dystonic Disorders (Writer's Cramp) 08/2009 - 01/2002
3	Chorea (Rheumatic Chorea) 10/2015 - 06/2004
3	Myoclonic dystonia 04/2015 - 02/2005
3	Dystonia musculorum deformans type 1 01/2011 - 04/2006
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/2024 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 03/2012
2	Disease Progression 02/2024 - 05/2012
2	Primary Cervical Dystonia 06/2013 - 08/2001
2	Dopa-responsive Dystonia 08/2009 - 04/2006
2	Dyskinesias (Dyskinesia) 02/2009 - 01/2001
2	Tics (Tic) 07/2004 - 06/2004
1	Corticobasal Degeneration 02/2024
1	Paralysis (Palsy) 01/2018
1	Huntington Disease (Huntington's Disease) 02/2014
1	Cerebellar Diseases (Cerebellar Syndrome) 07/2013
1	Wounds and Injuries (Trauma) 04/2013
1	Infections 04/2013
1	Depressive Disorder (Melancholia) 08/2009
1	Tremor (Tremors) 08/2009
1	Restless Legs Syndrome (Restless Legs) 08/2009
1	Dysphonia (Spastic Dysphonia) 08/2009
1	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 06/2009
1	Parkinson Disease (Parkinson's Disease) 02/2009
1	Myoclonus (Nocturnal Myoclonus) 05/2006
1	Type 2 Episodic Ataxia 09/2005
1	Unverricht-Lundborg Syndrome (Disease, Unverricht) 11/2002
1	Benign essential blepharospasm 01/2002
1	Blepharospasm 01/2002
1	Fatigue 01/2001
1	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 01/2001
1	Paroxysmal nonkinesigenic dyskinesia 01/2001
1	Sialorrhea 08/2000

Drug/Important Bio-Agent (IBA)

7	Botulinum Toxins (Botulinum Toxin)IBA 06/2013 - 01/2001
6	Levodopa (L Dopa)FDA LinkGeneric 01/2011 - 02/2006
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018 - 08/2001
3	Sarcoglycans (beta Sarcoglycan)IBA 04/2015 - 02/2005
3	IronIBA 02/2014 - 06/2009
3	AntibodiesIBA 07/2004 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 05/2012
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2015 - 05/2006
2	Dihydroxyphenylalanine (Dopa)IBA 04/2015 - 02/2006
2	Dopamine (Intropin)FDA LinkGeneric 04/2015 - 01/2010
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2002 - 08/2001
1	alpha-SynucleinIBA 02/2024
1	Tetrabenazine (Nitoman)FDA Link 04/2016
1	Indicators and Reagents (Reagents)IBA 07/2013
1	incobotulinumtoxinA FDA Link 01/2011
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 09/2009
1	Guanosine Triphosphate (GTP)IBA 08/2009
1	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2009
1	Dopamine Agents (Dopaminergic Agents)IBA 02/2009
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009
1	UbiquitinIBA 02/2008
1	Prostaglandins DIBA 12/2007
1	Baclofen FDA LinkGeneric 05/2006
1	Calcium Channels (Calcium Channel)IBA 09/2005
1	AntigensIBA 06/2004
1	AntioxidantsIBA 11/2002
1	Acetylcysteine (Siran)FDA LinkGeneric 11/2002
1	Glutathione (Reduced Glutathione)IBA 11/2002
1	Dopamine D5 ReceptorsIBA 08/2001
1	Coffee FDA Link 01/2001
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2001
1	TeaIBA 01/2001
1	Type A Botulinum Toxins (Botox)FDA Link 08/2000

Therapy/Procedure

4	Deep Brain Stimulation 01/2011 - 04/2006
4	Denervation 05/2006 - 01/2001
2	Therapeutics 10/2015 - 09/2000
2	Injections 09/2006 - 01/2001
1	Telescopes 08/2016
1	Cesarean Section (Caesarean Section) 04/2013
1	Transcranial Magnetic Stimulation 04/2009
1	Electrodes (Electrode) 12/2007